Top Issues Facing Pharma in 2020
January 11, 2020
Novel drugs, value-based contracting, biosimilars, and regulatory activity addressing costs will be among the hot button issues in the coming year.
Frieda Wiley, PharmD
The Benefits of Pharmacogenetic Testing
January 7, 2020
Payer education, evidence critical to providing cost-effective, beneficial treatment in pharmacogenetics.
Life-Altering Gene Therapy Pipeline Poses Challenges
September 5, 2019
What to expect for these high-dollar drugs.
